| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.09e-05 | 127 | 57 | 5 | GO:0008094 | |
| GeneOntologyCellularComponent | myosin filament | 4.24e-05 | 25 | 57 | 3 | GO:0032982 | |
| MousePheno | abnormal prenatal body size | EPRS1 ZFAT STXBP3 TRAF3IP1 UBR5 RSF1 MYO18A CKAP5 PKNOX1 WDFY3 PAK1IP1 RFC1 THOC2 | 2.49e-05 | 1116 | 44 | 13 | MP:0010866 |
| MousePheno | decreased cortical ventricular zone thickness | 9.62e-05 | 5 | 44 | 2 | MP:0014558 | |
| MousePheno | abnormal prenatal growth/weight/body size | EPRS1 ZFAT STXBP3 TRAF3IP1 UBR5 WNT2 RSF1 MYO18A CKAP5 PKNOX1 WDFY3 PAK1IP1 RFC1 THOC2 | 1.23e-04 | 1493 | 44 | 14 | MP:0004196 |
| MousePheno | abnormal cortical ventricular zone thickness | 1.44e-04 | 6 | 44 | 2 | MP:0014556 | |
| MousePheno | embryonic lethality prior to tooth bud stage | KANSL3 EPRS1 STXBP3 TRAF3IP1 MYO18A CKAP5 PKNOX1 AK2 EXOC1 PAK1IP1 RFC1 THOC2 ARHGAP21 | 2.28e-04 | 1383 | 44 | 13 | MP:0013293 |
| Domain | PH | 1.79e-04 | 278 | 56 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 1.83e-04 | 279 | 56 | 6 | PS50003 | |
| Domain | PH_domain | 1.86e-04 | 280 | 56 | 6 | IPR001849 | |
| Domain | PH_dom-like | 2.70e-04 | 426 | 56 | 7 | IPR011993 | |
| Domain | RhoGAP | 8.52e-04 | 62 | 56 | 3 | SM00324 | |
| Domain | RhoGAP | 8.93e-04 | 63 | 56 | 3 | PF00620 | |
| Domain | RHOGAP | 9.34e-04 | 64 | 56 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 9.34e-04 | 64 | 56 | 3 | IPR000198 | |
| Domain | - | 9.34e-04 | 64 | 56 | 3 | 1.10.555.10 | |
| Domain | - | 1.09e-03 | 391 | 56 | 6 | 2.30.29.30 | |
| Domain | IQ | 1.26e-03 | 71 | 56 | 3 | PF00612 | |
| Domain | Myosin_tail_1 | 1.31e-03 | 18 | 56 | 2 | PF01576 | |
| Domain | Myosin_tail | 1.31e-03 | 18 | 56 | 2 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.46e-03 | 19 | 56 | 2 | IPR027401 | |
| Domain | - | 1.46e-03 | 19 | 56 | 2 | 4.10.270.10 | |
| Domain | IQ | 1.85e-03 | 81 | 56 | 3 | SM00015 | |
| Domain | Rho_GTPase_activation_prot | 2.34e-03 | 88 | 56 | 3 | IPR008936 | |
| Domain | IQ_motif_EF-hand-BS | 2.49e-03 | 90 | 56 | 3 | IPR000048 | |
| Domain | IQ | 2.74e-03 | 93 | 56 | 3 | PS50096 | |
| Domain | PH | 4.91e-03 | 229 | 56 | 4 | PF00169 | |
| Domain | Myosin_head_motor_dom | 5.79e-03 | 38 | 56 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.79e-03 | 38 | 56 | 2 | PS51456 | |
| Domain | Myosin_head | 5.79e-03 | 38 | 56 | 2 | PF00063 | |
| Domain | MYSc | 5.79e-03 | 38 | 56 | 2 | SM00242 | |
| Pubmed | IVD EPRS1 MYH3 CENPF TCHHL1 U2SURP ARHGAP12 RSF1 MYO18A ANKRD26 MAGI3 PLCH1 NCAPH ARHGAP21 ESF1 | 9.49e-09 | 1442 | 58 | 15 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 PRCC U2SURP RSF1 CKAP5 ANKRD26 AK2 RFC1 THOC2 NCAPH ARHGAP21 ESF1 | 3.76e-08 | 934 | 58 | 12 | 33916271 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 CENPF KLHL7 MYO18A CKAP5 PUM3 PAK1IP1 RFC1 THOC2 NCAPH IKBIP ESF1 NSD3 | 1.17e-07 | 1257 | 58 | 13 | 36526897 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KANSL3 EPRS1 CENPF U2SURP HMGXB4 WRN CKAP5 HLTF RFC1 THOC2 IKBIP NSD3 | 1.22e-06 | 1294 | 58 | 12 | 30804502 |
| Pubmed | 1.29e-06 | 653 | 58 | 9 | 22586326 | ||
| Pubmed | 1.57e-06 | 340 | 58 | 7 | 24332808 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 UBR5 U2SURP RSF1 CKAP5 HLTF PUM3 EXOC1 WDFY3 RFC1 NCAPH ESF1 | 1.94e-06 | 1353 | 58 | 12 | 29467282 |
| Pubmed | RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks. | 2.43e-06 | 16 | 58 | 3 | 26474068 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 STXBP3 CENPF VPS13C U2SURP CKAP5 PUM3 PAK1IP1 RFC1 THOC2 NCAPH ESF1 | 3.32e-06 | 1425 | 58 | 12 | 30948266 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.64e-06 | 954 | 58 | 10 | 36373674 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.39e-06 | 759 | 58 | 9 | 35915203 | |
| Pubmed | 6.23e-06 | 1014 | 58 | 10 | 32416067 | ||
| Pubmed | EPRS1 FBXL16 TRAF3IP1 KLHL7 CKAP5 PKNOX1 MAGI3 EXOC1 WDFY3 ARHGAP21 BFSP1 | 7.75e-06 | 1285 | 58 | 11 | 35914814 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30335157 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30564305 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | STXBP3 UBR5 KLHL7 VPS13C ARHGAP12 CKAP5 ANKRD26 MAGI3 ARHGAP21 | 1.12e-05 | 853 | 58 | 9 | 28718761 |
| Pubmed | 1.14e-05 | 645 | 58 | 8 | 25281560 | ||
| Pubmed | 1.87e-05 | 497 | 58 | 7 | 23414517 | ||
| Pubmed | 2.70e-05 | 210 | 58 | 5 | 16565220 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 2.92e-05 | 736 | 58 | 8 | 29676528 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.92e-05 | 533 | 58 | 7 | 30554943 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 3.45e-05 | 221 | 58 | 5 | 29991511 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.17e-05 | 774 | 58 | 8 | 15302935 | |
| Pubmed | 4.73e-05 | 390 | 58 | 6 | 17643375 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 5.01e-05 | 394 | 58 | 6 | 27248496 | |
| Pubmed | Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice. | 5.71e-05 | 7 | 58 | 2 | 36897941 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.87e-05 | 1318 | 58 | 10 | 30463901 | |
| Pubmed | 6.37e-05 | 128 | 58 | 4 | 30995482 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.70e-05 | 608 | 58 | 7 | 36089195 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 7.61e-05 | 134 | 58 | 4 | 25452129 | |
| Pubmed | 8.28e-05 | 1103 | 58 | 9 | 34189442 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 9.05e-05 | 271 | 58 | 5 | 32433965 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.13e-04 | 1149 | 58 | 9 | 35446349 | |
| Pubmed | 1.27e-04 | 153 | 58 | 4 | 10718198 | ||
| Pubmed | 1.53e-04 | 483 | 58 | 6 | 36912080 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.58e-04 | 486 | 58 | 6 | 30940648 | |
| Pubmed | 1.72e-04 | 708 | 58 | 7 | 39231216 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 1.89e-04 | 719 | 58 | 7 | 35337019 | |
| Pubmed | 1.89e-04 | 963 | 58 | 8 | 28671696 | ||
| Pubmed | 1.90e-04 | 503 | 58 | 6 | 16964243 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.26e-04 | 989 | 58 | 8 | 36424410 | |
| Pubmed | 2.52e-04 | 754 | 58 | 7 | 35906200 | ||
| Pubmed | 3.02e-04 | 777 | 58 | 7 | 35844135 | ||
| Pubmed | 3.21e-04 | 195 | 58 | 4 | 19454010 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.34e-04 | 197 | 58 | 4 | 20811636 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.67e-04 | 202 | 58 | 4 | 33005030 | |
| Pubmed | 3.85e-04 | 809 | 58 | 7 | 32129710 | ||
| Pubmed | Role of Ostm1 Cytosolic Complex with Kinesin 5B in Intracellular Dispersion and Trafficking. | 4.11e-04 | 18 | 58 | 2 | 26598607 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.14e-04 | 582 | 58 | 6 | 20467437 | |
| Pubmed | 4.18e-04 | 1084 | 58 | 8 | 11544199 | ||
| Pubmed | 4.18e-04 | 1371 | 58 | 9 | 36244648 | ||
| Pubmed | 4.64e-04 | 215 | 58 | 4 | 30462309 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 4.66e-04 | 90 | 58 | 3 | 35654790 | |
| Pubmed | 5.06e-04 | 847 | 58 | 7 | 35850772 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 5.06e-04 | 847 | 58 | 7 | 35235311 | |
| Pubmed | 5.23e-04 | 222 | 58 | 4 | 35941108 | ||
| Pubmed | 5.46e-04 | 95 | 58 | 3 | 29490077 | ||
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 5.62e-04 | 21 | 58 | 2 | 27723720 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 6.09e-04 | 410 | 58 | 5 | 26949251 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.17e-04 | 232 | 58 | 4 | 25515538 | |
| Pubmed | 6.37e-04 | 234 | 58 | 4 | 36243803 | ||
| Pubmed | 6.49e-04 | 634 | 58 | 6 | 34591612 | ||
| Pubmed | 6.72e-04 | 419 | 58 | 5 | 15635413 | ||
| Pubmed | Genomic variants in an inbred mouse model predict mania-like behaviors. | 6.76e-04 | 23 | 58 | 2 | 29768498 | |
| Pubmed | 6.83e-04 | 1168 | 58 | 8 | 19946888 | ||
| Pubmed | 7.11e-04 | 104 | 58 | 3 | 31365120 | ||
| Pubmed | Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex. | 7.37e-04 | 24 | 58 | 2 | 35543156 | |
| Pubmed | 7.39e-04 | 650 | 58 | 6 | 38777146 | ||
| Pubmed | 7.55e-04 | 430 | 58 | 5 | 32581705 | ||
| Pubmed | 7.69e-04 | 655 | 58 | 6 | 35819319 | ||
| Pubmed | 8.45e-04 | 441 | 58 | 5 | 31239290 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.91e-04 | 256 | 58 | 4 | 33397691 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 9.30e-04 | 259 | 58 | 4 | 30404004 | |
| Pubmed | 9.53e-04 | 453 | 58 | 5 | 29656893 | ||
| Pubmed | DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination. | 1.00e-03 | 28 | 58 | 2 | 32937373 | |
| Pubmed | 1.05e-03 | 119 | 58 | 3 | 23508102 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.08e-03 | 120 | 58 | 3 | 31413325 | |
| Pubmed | 1.08e-03 | 29 | 58 | 2 | 21998595 | ||
| Pubmed | 1.11e-03 | 469 | 58 | 5 | 27634302 | ||
| Pubmed | 1.14e-03 | 472 | 58 | 5 | 38943005 | ||
| Pubmed | 1.14e-03 | 274 | 58 | 4 | 34244482 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.29e-03 | 283 | 58 | 4 | 30585729 | |
| Pubmed | HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. | 1.31e-03 | 32 | 58 | 2 | 27114546 | |
| Pubmed | 1.35e-03 | 731 | 58 | 6 | 29298432 | ||
| Pubmed | 1.36e-03 | 130 | 58 | 3 | 12421765 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.36e-03 | 732 | 58 | 6 | 34732716 | |
| Pubmed | 1.39e-03 | 493 | 58 | 5 | 15368895 | ||
| Pubmed | 1.48e-03 | 34 | 58 | 2 | 20301725 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.50e-03 | 1321 | 58 | 8 | 27173435 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.53e-03 | 1024 | 58 | 7 | 24711643 | |
| Pubmed | 1.55e-03 | 506 | 58 | 5 | 30890647 | ||
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 1.57e-03 | 35 | 58 | 2 | 29104064 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 1.66e-03 | 36 | 58 | 2 | 26053890 | |
| Interaction | HECTD1 interactions | EPRS1 CENPF U2SURP WRN MYO18A CKAP5 PUM3 ZNF215 EXOC1 PAK1IP1 RFC1 THOC2 NCAPH ESF1 | 5.41e-07 | 984 | 58 | 14 | int:HECTD1 |
| Interaction | NAA40 interactions | EPRS1 PRCC U2SURP RSF1 CKAP5 ANKRD26 AK2 RFC1 THOC2 NCAPH ARHGAP21 ESF1 | 1.80e-05 | 978 | 58 | 12 | int:NAA40 |
| Interaction | CAVIN1 interactions | 1.99e-05 | 292 | 58 | 7 | int:CAVIN1 | |
| Interaction | TERF2IP interactions | 2.62e-05 | 552 | 58 | 9 | int:TERF2IP | |
| Interaction | H1-5 interactions | 5.11e-05 | 463 | 58 | 8 | int:H1-5 | |
| Interaction | NUP43 interactions | 6.87e-05 | 625 | 58 | 9 | int:NUP43 | |
| Interaction | YWHAZ interactions | IVD KLHL7 KMT5B PRCC RSF1 MYO18A CKAP5 ANKRD26 ARHGEF18 PUM3 WDFY3 PLCH1 ARHGAP21 | 7.53e-05 | 1319 | 58 | 13 | int:YWHAZ |
| Interaction | CENPA interactions | 1.00e-04 | 377 | 58 | 7 | int:CENPA | |
| Cytoband | 20p12.1 | 4.62e-04 | 25 | 58 | 2 | 20p12.1 | |
| Cytoband | 10p12.1 | 7.59e-04 | 32 | 58 | 2 | 10p12.1 | |
| Cytoband | 15q25.2 | 1.37e-03 | 43 | 58 | 2 | 15q25.2 | |
| Cytoband | 8p12 | 1.63e-03 | 47 | 58 | 2 | 8p12 | |
| Cytoband | 1q41 | 3.19e-03 | 66 | 58 | 2 | 1q41 | |
| Cytoband | 2q11.2 | 3.79e-03 | 72 | 58 | 2 | 2q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p12 | 3.79e-03 | 72 | 58 | 2 | chr8p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 6.23e-03 | 93 | 58 | 2 | chr1q41 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.83e-04 | 50 | 40 | 3 | 721 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.56e-03 | 34 | 40 | 2 | 487 | |
| GeneFamily | PDZ domain containing | 4.58e-03 | 152 | 40 | 3 | 1220 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STXBP3 UBR5 CENPF U2SURP ARHGAP12 HMGXB4 WRN CKAP5 HLTF PUM3 WDFY3 THOC2 | 2.49e-07 | 856 | 57 | 12 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.35e-06 | 656 | 57 | 10 | M18979 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 7.24e-06 | 466 | 57 | 8 | M13522 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 2.37e-05 | 721 | 57 | 9 | M10237 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 3.74e-05 | 426 | 57 | 7 | M9516 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 3.91e-05 | 429 | 57 | 7 | M29 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 5.03e-05 | 184 | 57 | 5 | M9005 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 7.46e-05 | 200 | 57 | 5 | M4617 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 7.46e-05 | 200 | 57 | 5 | M7500 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP | 7.46e-05 | 200 | 57 | 5 | M8853 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | 8.81e-05 | 662 | 57 | 8 | M8124 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.19e-04 | 221 | 57 | 5 | M39222 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9 | 1.29e-04 | 8 | 57 | 2 | M9239 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 1.62e-04 | 236 | 57 | 5 | M130 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | EPRS1 CENPF U2SURP HMGXB4 WRN CKAP5 AK2 RFC1 NCAPH IKBIP NSD3 | 1.93e-04 | 1407 | 57 | 11 | M14427 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.34e-06 | 532 | 57 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.25e-05 | 192 | 57 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | EPRS1 TRAF3IP1 UBR5 CENPF U2SURP CKAP5 ANKRD26 PUM3 PLCH1 ARHGAP21 ESF1 | 5.45e-05 | 989 | 57 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.32e-07 | 199 | 58 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.25e-06 | 193 | 58 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.81e-06 | 197 | 58 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.95e-06 | 198 | 58 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.10e-06 | 199 | 58 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 6.10e-06 | 199 | 58 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 6.25e-06 | 200 | 58 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-05 | 134 | 58 | 4 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.49e-05 | 151 | 58 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.85e-05 | 154 | 58 | 4 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.28e-05 | 171 | 58 | 4 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 7.45e-05 | 172 | 58 | 4 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.62e-05 | 173 | 58 | 4 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 175 | 58 | 4 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 177 | 58 | 4 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.32e-05 | 177 | 58 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Ciliated_cells-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 8.69e-05 | 179 | 58 | 4 | 1c41314b6fcfcac8d62034e7037570120d58f20f | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 9.67e-05 | 184 | 58 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 186 | 58 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 188 | 58 | 4 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 189 | 58 | 4 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 191 | 58 | 4 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.31e-04 | 199 | 58 | 4 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-04 | 199 | 58 | 4 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-04 | 199 | 58 | 4 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 1.33e-04 | 200 | 58 | 4 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 1.33e-04 | 200 | 58 | 4 | 9769185abae084ffac36420c749625e679b70ca8 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.32e-06 | 174 | 58 | 6 | 7530_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 3699_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A | 1.18e-05 | 200 | 58 | 6 | 7151_DN | |
| Disease | exercise test | 6.81e-04 | 20 | 57 | 2 | EFO_0004328 | |
| Disease | cerebral amyloid deposition measurement | 8.34e-04 | 95 | 57 | 3 | EFO_0007707 | |
| Disease | Retinitis Pigmentosa | 1.08e-03 | 104 | 57 | 3 | C0035334 | |
| Disease | Dupuytren Contracture | 1.21e-03 | 108 | 57 | 3 | EFO_0004229 | |
| Disease | insomnia measurement | 1.64e-03 | 443 | 57 | 5 | EFO_0007876 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MDTKKKKDVSSPGGS | 6 | Q9UGJ0 | |
| EIAGKMDLKSSSKLK | 656 | Q6ZSZ5 | |
| MVKKKGIAAKSSKTS | 81 | Q5JRM2 | |
| MKKIFSKKGESPLGS | 1 | Q9UPS8 | |
| MKCTKVGGSDKAKAK | 101 | P78369 | |
| SKSTIKKINKDKSMG | 191 | Q8IWA6 | |
| TFEGTGPTKKKAKMR | 166 | Q9NS39 | |
| MEVKGKKQFTGKSTK | 1 | Q15397 | |
| KPEKKSASSGEMSKK | 301 | Q8TDR0 | |
| TKTAKMKTDKKENAG | 661 | Q5TCQ9 | |
| DTGMSKKKSRQGKLV | 606 | Q4FZB7 | |
| GKKLKATMDAGKLVS | 61 | P54819 | |
| GIKKMKTSCKFKIDS | 136 | Q9H501 | |
| RKTFTTGMAAVKKKS | 1006 | Q92614 | |
| KTDKTQTMKTPKGLG | 361 | Q8N4P6 | |
| MAASGVEKSSKKKTE | 1 | Q8IXQ5 | |
| KKKKKSSPQSTDTAM | 96 | Q9UGU5 | |
| KRKASSSEGSMKVKA | 476 | Q9UGU5 | |
| EKGMPGFSTSKKLDK | 231 | P26440 | |
| MSEVKSRKKSGPKGA | 1 | Q70UQ0 | |
| GATIEMASKDKSSKK | 526 | Q8IWW6 | |
| GKKLSSSSKVGMEVK | 1111 | Q5VST9 | |
| KDGKKLSSSSKVRME | 1201 | Q5VST9 | |
| AKSAQGKKMPSKTSL | 1136 | Q14008 | |
| ESFSKKSKKAVMSGI | 2951 | P49454 | |
| VETMIGKTKSDKKKS | 646 | Q12934 | |
| ISKAKKKSEGLTQSM | 441 | Q9P2N6 | |
| IKMTGTTKESKKFAT | 431 | Q9NV70 | |
| SSVPTTKKKMLKKGA | 446 | Q14527 | |
| KCMEGLKTSFPKTGK | 2071 | Q8NDH2 | |
| SCTMKGEEKSPKTKK | 561 | Q96T23 | |
| SKKGVKAMSLKRSTI | 191 | Q8N461 | |
| RLAGGSCTKKKMKTL | 26 | Q9P2F6 | |
| HTKEMPTSGSKEKTK | 706 | P07814 | |
| TEEKTMKSFSKKKGE | 431 | Q92733 | |
| MLDSSCSETPKTKKK | 321 | P55347 | |
| TDAMIKKKTKSSKPS | 1116 | P35251 | |
| ATGDLAKKKDSKMKG | 201 | P11055 | |
| DTSKKLMDKTKRGGL | 1416 | Q14191 | |
| KLMKEISSTKKATEG | 306 | O00186 | |
| IGKMSTAKRTLSKKE | 86 | O15042 | |
| SATEMGTTKKAVKPK | 201 | Q15003 | |
| AEMPKKAGATTKGKS | 26 | Q8WUR7 | |
| GTKMRKTKKKGSGEA | 191 | O00294 | |
| KVDVDSSGKKCKEKM | 201 | Q9Y3V2 | |
| SSGKKCKEKMISVLF | 206 | Q9Y3V2 | |
| SCDPKKMGSAKDSKG | 136 | P09544 | |
| MCGKKFKSKGTLKSH | 941 | Q9P243 | |
| KSEKMDKISSGGKKE | 1546 | Q8NI27 | |
| EMGTSKEKAKTVTLK | 3106 | Q8IZQ1 | |
| KGKVKTKKLQSMLGS | 281 | Q8N0Z6 | |
| PQTCKSMKGSELKKA | 886 | Q709C8 | |
| ATKESGLISTKKRKM | 361 | Q9NWT1 | |
| MIPSSSASKKKCEKG | 906 | Q9BZ95 | |
| TASAPAKGRKKSKMG | 921 | Q4KWH8 | |
| SIKEKMKAGSRTGKP | 146 | Q9UL58 | |
| LKTNKPMAGSKKTSS | 206 | Q5QJ38 | |
| KTSGEKKCLSRKSMA | 1096 | Q9BXT5 | |
| TKVFDVMKKGKSTGS | 1731 | Q5T5U3 | |
| AKNKKPKSSAGISSM | 511 | O95071 | |
| SKIKSEMKTKLGEQG | 881 | P82987 |